Innoviva, INC Form 4 insider transactions

Stephen Basso, CFO of Innoviva, Inc., reports acquisition of shares through an employee stock purchase plan and shares withheld for tax obligations.

Innoviva's Chief Accounting Officer, Marianne Zhen, reported acquiring 300 shares through the employee stock purchase plan and disposing of 976 shares to cover tax obligations.

Marianne Zhen, Chief Accounting Officer of Innoviva, Inc., reports a transaction involving common stock to cover income tax withholding obligations.

Director Sapna Srivastava reports acquisition of 13,923 common stock shares and disposal of 44,096 shares, along with the grant of stock options.

Director Derek Small reports acquisition of Innoviva stock and options following the company's annual meeting.

Director Sarah J. Schlesinger reports acquisition of Innoviva stock and options following the company's annual meeting.

Director Odysseas Kostas D of Innoviva, Inc. reports acquisition of common stock and stock options following the company's annual meeting.

Director Jules Haimovitz reports acquiring shares and stock options in Innoviva, Inc. following the company's annual meeting.

Director Mark DiPaolo reports receiving restricted stock units and options from Innoviva, Inc. following the company's 2024 annual meeting of stockholders.

Matthew Ronsheim, an officer at Innoviva, Inc., reports the withholding of shares to cover income tax obligations related to equity grants.

Marianne Zhen, Chief Accounting Officer of Innoviva, Inc., reports the withholding of shares to cover income tax obligations related to equity grants.

Innoviva's Chief Financial Officer, Stephen Basso, reports the acquisition of common stock and stock options in the company.

Matthew Ronsheim, President of Innoviva Specialty Therapeutics, reports the acquisition of restricted stock units and non-statutory stock options in Innoviva, Inc.

Marianne Zhen, Chief Accounting Officer of Innoviva, Inc., reports the acquisition of stock and option awards.

Innoviva's CEO, Pavel Raifeld, reports acquisition of stock options and updates to his beneficial ownership of company stock.